- Home
- ABT vs TMO Comparison
ABT vs TMO Comparison
Compare ABT & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABT | TMO |
|---|---|---|
| Founded | 1888 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.8B | 216.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ABT | TMO |
|---|---|---|
| Price | $122.48 | $571.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 20 |
| Target Price | $146.61 | ★ $626.21 |
| AVG Volume (30 Days) | ★ 6.6M | 1.6M |
| Earning Date | 01-21-2026 | 01-29-2026 |
| Dividend Yield | ★ 1.93% | 0.30% |
| EPS Growth | ★ 141.97 | 8.54 |
| EPS | 7.96 | ★ 17.32 |
| Revenue | ★ $43,843,000,000.00 | $43,736,000,000.00 |
| Revenue This Year | $7.56 | $4.33 |
| Revenue Next Year | $7.96 | $4.94 |
| P/E Ratio | ★ $15.39 | $33.14 |
| Revenue Growth | ★ 6.37 | 3.22 |
| 52 Week Low | $110.86 | $385.46 |
| 52 Week High | $141.23 | $610.97 |
Technical Indicators
Market Signals| Indicator | ABT | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 37.46 | 51.55 |
| Support Level | $124.06 | $561.91 |
| Resistance Level | $126.05 | $575.25 |
| Average True Range (ATR) | 2.51 | 12.06 |
| MACD | -0.58 | -3.65 |
| Stochastic Oscillator | 18.25 | 33.58 |
Price Performance
Historical ComparisonAbout ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).